急性脑梗死合并2型糖尿病患者血清ALCAM、PECAM-1水平与颈动脉斑块稳定性的关系

doi:10.3969/j.issn.1671-7171.2022.10.026

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1126 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨急性脑梗死合并2型糖尿病患者血清活化白细胞黏附分子(ALCAM)、血小板内皮细胞黏附分子-1(PECAM-1)水平与颈动脉斑块稳定性的关系。【方法】选择在两院住院确诊的急性脑梗死合并2型糖尿病患者80例(观察组),另选取同期本院住院确诊的65例不伴2型糖尿病的急性脑梗死患者(对照组)。比较两组患者ALCAM、PECAM-1的水平,观察急性脑梗死合并2型糖尿病患者ALCAM、PECAM-1与颈动脉斑块稳定性和内部血管形成分级的关系。采用Pearson相关分析法分析ALCAM、PECAM-1与急性脑梗死合并2型糖尿病患者美国国立卫生院卒中量表(NIHSS)评分的关系。【结果】观察组ALCAM、PECAM-1水平均高于对照组(P<0.05)。观察组80例患者中无斑块11例,稳定斑块24例,不稳定斑块45例;无斑块患者ALCAM、PECAM-1水平低于稳定斑块患者和不稳定斑块患者(P<0.05),稳定斑块患者ALCAM、PECAM-1水平低于不稳定斑块患者(P<0.05)。80例患者中颈动脉斑块内部血管形成分级为0～1级的患者39例,2～3级患者41例,其中0～1级患者ALCAM、PECAM-1水平低于2～3级患者(P<0.05)。急性脑梗死合并2型糖尿病患者ALCAM、PECAM-1水平与NIHSS评分均呈正相关(均P<0.05)。【结论】ALCAM、PECAM-1在急性脑梗死合并2型糖尿病患者血清中的表达水平明显升高,其不仅与颈动脉斑块的稳定性、内部血管形成分级密切相关,还与患者神经功能受损程度呈显著正相关,临床应引起重视。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	孙秀娟
	雷光锋

关键词 ：脑梗死/并发症, 糖尿病/并发症, 活化白细胞黏附分子/血液, 血小板内皮细胞黏附分子1/血液, 斑块, 动脉粥样硬化

Abstract：【Objective】To investigate the relationship of carotid plaque stability with serum levels of activated leukocyte cell adhesion molecule (ALCAM) and platelet endothelial cell adhesion molecule-1 (PECAM-1) in patients with acute cerebral infarction complicated with type 2 diabetes mellitus. 【Methods】A total of 80 patients with acute cerebral infarction complicated with type 2 diabetes diagnosed in our hospital were selected as the observation group, while 65 acute cerebral infarction patients without type 2 diabetes in our hospital in the same period were selected as the control group. The levels of ALCAM and PECAM-1 were detected and compared between the two groups, and the relationship of carotid plaque stability and internal vessel formation grade with ALCAM and PECAM-1 in patients with acute cerebral infarction complicated with type 2 diabetes mellitus was analyzed. Pearson correlation analysis was used to analyze the relationship among ALCAM, PECAM-1 and NIHSS score in patients with acute cerebral infarction complicated with type 2 diabetes mellitus.【Results】The levels of ALCAM and PECAM-1 in the observation group were higher than those in the control group (all P<0.05). In the observation group, there were 11 cases without plaque, 24 cases with stable plaque and 45 cases with unstable plaque. The levels of ALCAM and PECAM-1 in patients without plaque were lower than those in patients with stable plaque and unstable plaque (all P<0.05), and the levels of ALCAM and PECAM-1 in patients with stable plaque were lower than those in patients with unstable plaque (all P<0.05). Among the 80 patients, 39 patients had carotid plaque internal vascularization grade of 0～1 and 41 patients had grade 2～3. The levels of ALCAM and PECAM-1 in grade 0～1 patients were lower than those in grade 2～3 patients (all P<0.05). The levels of ALCAM and PECAM-1 were positively correlated with NIHSS score in patients with acute cerebral infarction complicated with type 2 diabetes mellitus (all P<0.05).【Conclusion】 Serum levels of ALCAM and PECAM-1 in patients with acute cerebral infarction complicated with type 2 diabetes mellitus are significantly increased, which are not only closely related to the stability of carotid plaque and internal vascular formation grade, but also significantly positively related to the degree of neurological impairment. Thus, in clinical practice the relationship should be paid attention to.

Key words： Brain Infarction/CO Diabetes Mellitus/CO Activated-Leukocyte Cell Adhesion Molecule/BL Platelet Endothelial Cell Adhesion Molecule-1/BL Plaque, Atherosclerotic

收稿日期: 2022-03-07

中图分类号:

R743.33

通讯作者: *E-mail:475012112@qq.com

引用本文:

孙秀娟, 雷光锋. 急性脑梗死合并2型糖尿病患者血清ALCAM、PECAM-1水平与颈动脉斑块稳定性的关系[J]. 医学临床研究, 2022, 39(10): 1535-1538.
SUN Xiu-juan, LEI Guang-feng. Relationship of Carotid Plaque Stability with Serum ALCAM and PECAM-1 in Patients with Acute Cerebral Infarction and Type 2 Diabetes Mellitus. JOURNAL OF CLINICAL RESEARCH, 2022, 39(10): 1535-1538.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2022.10.026 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2022/V39/I10/1535

[1] 吴俊慧,武轶群,吴瑶,等.北京城镇职工2型糖尿病患者缺血性脑卒中发病率及主要危险因素[J].北京大学学报(医学版),2022,54(2):249-254.
[2] YANG Y,SANDERS A J,RUGE F,et al.Activated leukocyte cell adhesion molecule (ALCAM)/CD166 in pancreatic cancer,a pivotal link to clinical outcome and vascular embolism[J].Am J Cancer Res,2021,11(12):5917-5932.
[3] TAREK B,BRUGGISSER J,CATTALANI F,et al.Platelet endothelial cell adhesion molecule 1 (CD31) is essential for clostridium perfringens beta-toxin mediated cytotoxicity in human endothelial and monocytic cells[J].Toxins (Basel),2021,13(12):893-1006.
[4] ESHAQ R S,HARRIS N R.Loss of platelet endothelial cell adhesion molecule-1 (PECAM-1) in the diabetic retina:role of matrix metalloproteinases[J].Invest Ophthalmol Vis Sci,2019,60(2):748-760.
[5] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
[6] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.
[7] SHAH F,BALAN P,WEINBERG M,et al.Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization:a new surrogate marker of atherosclerosis?[J].Vasc Med,2007,12(4):291-297.
[8] 中华医学会神经病学分会神经康复学组,中华医学会神经病学分会脑血管病学组,卫生部脑卒中筛查与防治工程委员会办公室,等.中国脑卒中康复治疗指南(2011完全版)[J].中国康复理论与实践,2012,18(4):301-318.
[9] ZHANG Z,QIAN M,GE Z,et al.Effects of blood glucose and glycosylated hemoglobin levels on intravenous thrombolysis in patients with acute cerebral infarction and type 2 diabetes mellitus[J].Pak J Med Sci,2019,35(3):862-867.
[10] 陈兰英,徐添,杨辉,等.糖尿病合并脑卒中患者医院感染风险预测模型构建及经济负担评价[J].中华医院感染学杂志,2021,31(14):2104-2108.
[11] LUO H,ZHANG D,WANG F,et al.ALCAM-EGFR interaction regulates myelomagenesis[J].Blood Adv,2021,5(23):5269-5282.
[12] MARCINCZYK N,MISZTAL T,GROMOTOWICZ-POPLAWSKA A,et al.Utility of platelet endothelial cell adhesion molecule 1 in the platelet activity assessment in mouse and human blood[J].Int J Mol Sci,2021,22(17):9611-9623.
[13] van SLOTEN TT,SEDAGHAT S,CAMETHON MR,et al.Cerebral microvascular complications of type 2 diabetes:stroke,cognitive dysfunction,and depression[J].Lancet Diabetes Endocrinol,2020,8(4):325-336.
[14] DESPA F,GOLDSTEIN LB.Amylin dyshomeostasis hypothesis:small vessel-type ischemic stroke in the setting of type-2 diabetes[J].Stroke,2021,52(6):244-249.